.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Moodys
Teva
Johnson and Johnson
Queensland Health
Fuji
Colorcon
Fish and Richardson
Julphar

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,846,091

« Back to Dashboard

Which drugs does patent 8,846,091 protect, and when does it expire?


Patent 8,846,091 protects TARGINIQ and is included in one NDA.

This patent has one hundred and three patent family members in thirty-one countries.

Summary for Patent: 8,846,091

Title:Matrix for sustained, invariant and independent release of active compounds
Abstract: The invention concerns a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics by ethylcellulose and at least one fatty alcohol. The invention also concerns methods for producing such pharmaceutical formulations.
Inventor(s): Brogmann; Bianca (Ulm, DE), Muhlah; Silke (Biberach, DE), Spitzley; Christof (Elbtal, DE)
Assignee: Euro-Celtique S.A. (Luxembourg, LU)
Application Number:14/058,108
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-001Jul 23, 2014DISCNYesNo► Subscribe► SubscribeY► Subscribe
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-002Jul 23, 2014DISCNYesNo► Subscribe► SubscribeY► Subscribe
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-003Jul 23, 2014DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,846,091

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 15 067Apr 5, 2002
Germany102 15 131Apr 5, 2002

Non-Orange Book Patents for Patent: 8,846,091

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,846,090Matrix for sustained, invariant and independent release of active compounds► Subscribe
9,655,855Matrix for sustained, invariant and independent release of active compounds► Subscribe
9,555,000Pharmaceutical preparation containing oxycodone and naloxone► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,846,091

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark1492506► Subscribe
Cyprus1116640► Subscribe
Germany10215067► Subscribe
Germany10215068► Subscribe
Germany10215131► Subscribe
Germany20308436► Subscribe
Germany20308437► Subscribe
Germany20321531► Subscribe
Germany60325567► Subscribe
Denmark1492505► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Citi
Novartis
Express Scripts
Covington
Cantor Fitzgerald
Argus Health
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot